Ensysce Biosciences (ENSC) Selling, General & Administrative (2020 - 2025)
Ensysce Biosciences (ENSC) reported Selling, General & Administrative of $1.28 million for Q3 2025, up 18.1% from $1.08 million a year earlier and up 6.7% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Selling, General & Administrative (2020 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Ensysce Biosciences' Selling, General & Administrative came in at $4.96 million, down 2.4% year-over-year; for FY2024, it came in at $4.72 million, down 11.9% from FY2023.
- Selling, General & Administrative has declined for three consecutive years, though with a four-year compound annual growth rate of 42.2% (FY2020 to FY2024).
- By year, Selling, General & Administrative came in at $5.36 million in FY2023 (-22.4%), $6.91 million in FY2022 (-63.1%), $18.71 million in FY2021 and $1.15 million in FY2020.
- Five-year quarterly Selling, General & Administrative spans a low of $256,447 in Q4 2020 and a high of $16.37 million in Q3 2021.
- Year over year, Selling, General & Administrative has now increased in each of the last three quarters, with an average decline of 0.3% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was Q4 2021 (growth of 467.1%); the low point was Q3 2022 (a decline of 89.7%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $1.2 million (Q2 2025), $1.4 million (Q1 2025) and $1.08 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Ensysce Biosciences | 1.02 Mn | -10.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.23 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 1.55 Mn |
| Dec 31, 2022 | 1.19 Mn |
| Sep 30, 2022 | 1.69 Mn |
| Jun 30, 2022 | 1.95 Mn |
| Mar 31, 2022 | 2.27 Mn |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | 16.37 Mn |
| Jun 30, 2021 | 393,914.00 |
| Mar 31, 2021 | 490,471.00 |
| Dec 31, 2020 | 256,447.00 |
API Access
Ensysce Biosciences Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();